HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,704,176 | +1552.2% | 227,858 | +1460.0% | 0.02% | +2000.0% |
| Q2 2023 | $526,838 | -72.3% | 14,606 | -56.3% | 0.00% | -97.1% |
| Q4 2022 | $1,900,460 | +771.8% | 33,400 | +507.3% | 0.03% | +750.0% |
| Q3 2022 | $218,000 | -56.4% | 5,500 | -51.6% | 0.00% | -71.4% |
| Q2 2022 | $500,000 | +43.7% | 11,372 | +31.3% | 0.01% | +27.3% |
| Q4 2021 | $348,000 | +6.4% | 8,663 | -59.0% | 0.01% | -42.1% |
| Q3 2019 | $327,000 | -62.4% | 21,120 | -58.3% | 0.02% | -80.2% |
| Q2 2019 | $870,000 | – | 50,610 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |